A comparative analysis of POLR2A expression across multiple cancer types, conducted using the GEPIA2 platform (Tang et al., 2019), revealed substantial upregulation of POLR2A in malignancies such as acute myeloid leukemia and thymoma. Here, POLR2A is linked to acute myeloid leukemia.